Abstract
For more than 150 years there has been some level of scientific argument regarding whether aging in humans and other mammals is purposely genetically programmed because living too long produces an evolutionary disadvantage, or whether aging in mammals is non-programmed because there is no such disadvantage. Although for many decades it was very widely thought that programmed aging in mammals was theoretically impossible, new evolutionary mechanics theories and new discoveries support programmed mammal aging as well as programmed lifespan limitation in non-mammals. The emergence of modern programmed aging theories has created a schism in the bioscience community regarding the programmed/ non-programmed issue. Because the two theories have radically different predictions regarding the fundamental nature of aging and consequently the nature of highly age-related diseases like cancer, stroke, and heart disease, resolving this issue is critical to medical research.
This article summarizes the evolutionary mechanics basis of modern programmed and non-programmed aging theories, describes some of the many ancillary circumstances that continue to prevent resolution of this issue, and recommends steps that could be taken to rapidly resolve the programmed/ non-programmed conundrum.
Keywords: Ageing, aging, senescence, medicine, research policy, gerontology, evolution.
Current Aging Science
Title:Solving the Programmed/Non-Programmed Aging Conundrum
Volume: 8 Issue: 1
Author(s): Theodore C. Goldsmith
Affiliation:
Keywords: Ageing, aging, senescence, medicine, research policy, gerontology, evolution.
Abstract: For more than 150 years there has been some level of scientific argument regarding whether aging in humans and other mammals is purposely genetically programmed because living too long produces an evolutionary disadvantage, or whether aging in mammals is non-programmed because there is no such disadvantage. Although for many decades it was very widely thought that programmed aging in mammals was theoretically impossible, new evolutionary mechanics theories and new discoveries support programmed mammal aging as well as programmed lifespan limitation in non-mammals. The emergence of modern programmed aging theories has created a schism in the bioscience community regarding the programmed/ non-programmed issue. Because the two theories have radically different predictions regarding the fundamental nature of aging and consequently the nature of highly age-related diseases like cancer, stroke, and heart disease, resolving this issue is critical to medical research.
This article summarizes the evolutionary mechanics basis of modern programmed and non-programmed aging theories, describes some of the many ancillary circumstances that continue to prevent resolution of this issue, and recommends steps that could be taken to rapidly resolve the programmed/ non-programmed conundrum.
Export Options
About this article
Cite this article as:
Goldsmith C. Theodore, Solving the Programmed/Non-Programmed Aging Conundrum, Current Aging Science 2015; 8 (1) . https://dx.doi.org/10.2174/1874609808666150421131841
DOI https://dx.doi.org/10.2174/1874609808666150421131841 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nutraceuticals for Metabolic Syndrome Management: From Laboratory to Benchside
Current Vascular Pharmacology Therapeutic Hypothermia in Brain Injuries and Related Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Current Drug Safety Safety Considerations in the Use of Ketorolac for Postoperative Pain
Current Drug Safety Potential Treatment of Cardiac Hypertrophy and Heart Failure by Inhibiting the Sarcolemmal Binding of Phospholipase Cβ1b
Current Drug Targets Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges
Current Topics in Medicinal Chemistry Adherence to Treatment, Arterial Stiffness and Cognitive Function in Irbesartan- Treated Newly Diagnosed Hypertensive Patients
Current Vascular Pharmacology The Metabolic Syndrome and Chronic Liver Disease
Current Pharmaceutical Design Orthostatic Hypotension: Evaluation and Treatment
Cardiovascular & Hematological Disorders-Drug Targets Hypolipidemic, Antioxidant and Cardioprotective Effects of the Aqueous Extract from <i>Scorzanera Undulata</i> Tubers in Streptozotocin-Induced Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Pexelizumab, an Anti-C5 Complement Antibody for Primary Coronary Revascularization: A New Insight from Old Versions
Cardiovascular & Hematological Disorders-Drug Targets Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Lower Serum Indirect Bilirubin Levels are Inversely Related to Carotid Intima-Media Thickness Progression
Current Neurovascular Research The Role of Inflammation and Allergy in Acute Coronary Syndromes
Inflammation & Allergy - Drug Targets (Discontinued) Biochemical, Hematological and Histopathological Indices of Wistar Rats Fed Vitamin and Mineral Deficient Diets Supplemented with Moringa oleifera Leaf Meal
Current Nutrition & Food Science Obstructive Sleep Apnea and Cardiovascular Disease - A New Target for Treatment
Current Pharmaceutical Design Cardiovascular Remodeling Induced by Passive Smoking
Inflammation & Allergy - Drug Targets (Discontinued) Linezolid - The First Oxazolidinone in the Treatment of Nosocomial MRSA Pneumonia
Recent Patents on Anti-Infective Drug Discovery Combination of Statin Plus Renin Angiotensin System Inhibition for the Prevention or the Treatment of Atherosclerotic Cardiovascular Disease
Current Pharmaceutical Design Mediterranean Diet And Longevity: An Example Of Nutraceuticals?
Current Vascular Pharmacology